GE HEALTHCARE TECHNOLOGY GEHC
ASignal's systematic analysis rates GEHC as Neutral.
Reflects the latest available analysis · analyzed Nov 12, 2026
The case on GEHC
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong earnings growth (39.00% YoY)
- Healthy return on equity (20.01%)
- Positive free cash flow ($1.83B)
- MACD above signal line indicating bullish momentum
- Price above 20-day and 50-day moving averages
- RSI at 74.74 indicating overbought conditions
- High PEG ratio (2.24x) suggesting overvaluation relative to growth
- Low retail sentiment with zero Reddit mentions
- Limited news coverage from only two sources
- Quick ratio below 1.0 (0.88x) indicating liquidity concerns
Peers
Clustered with GEHC by analysis-profile similarity.
See the full verdict on GEHC
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes GEHC
Most investors never get a second opinion, let alone several. ASignal runs GEHC past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.